Garen Saraffin
Vice President of Investor Relations at Bausch Health
Replay available
Bausch Health Companies Inc. (NYSE: BHC) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations at Bausch Health
Chief Executive Officer at Bausch Health
Chief Financial Officer at Bausch Health
Chief Medical Officer and Head of Research and Development at Bausch Health
Raymond James
Evercore ISI
RBC Capital Markets
TD Cowen
Watch the replay and follow the connected company analysis, news, and investor updates for Bausch Health Companies Inc..
WEBVTT NOTE Transcription provided by Deepgram Request Id: 01a04220-1615-7c60-aefe-7ac4b7b3672f Created: 2026-08-27T07:29:56.301Z Duration: 2702.7332 Channels: 1 00:00:00.000 -- 00:00:03.280 Greetings, and welcome to the Bausch Health Second 00:00:03.280 -- 00:00:06.400 Quarter twenty twenty six Earnings Conference Call. 00:00:06.480 -- 00:00:08.639 At this time, all participants are in a 00:00:08.639 -- 00:00:11.519 listen only mode. A question and answer session 00:00:11.519 -- 00:00:13.280 will follow the formal presentation. 00:00:13.785 -- 00:00:14.665 As 00:00:20.744 -- 00:00:23.224 a reminder, this conference is being recorded. 00:00:23.465 -- 00:00:26.105 I'll now turn the conference over to Garen 00:00:26.425 -- 00:00:27.465 Saraffin, 00:00:27.705 -- 00:00:29.919 Vice President, Investor Relations. 00:00:29.920 -- 00:00:31.759 Thank you, Garen. You may begin. 00:00:32.479 -- 00:00:35.680 Good afternoon and welcome to Bausch Health's second 00:00:35.680 -- 00:00:38.399 quarter twenty twenty six earnings conference call. 00:00:38.720 -- 00:00:41.280 My name is Garen Saraffin, Vice President of 00:00:41.280 -- 00:00:42.079 Investor Relations. 00:00:42.935 -- 00:00:46.535 Participating in today's calls are Tom Appio, Chief 00:00:46.535 -- 00:00:50.855 Executive Officer JJ Charon, Chief Financial Officer and 00:00:50.855 -- 00:00:52.135 Jonathan Sadeh, 00:00:52.135 -- 00:00:54.775 Chief Medical Officer and Head of Research and 00:00:54.775 -- 00:00:55.175 Development. 00:00:56.620 -- 00:00:58.540 Before we begin, I would like to remind 00:00:58.540 -- 00:01:01.980 you that today's presentation contains forward looking information. 00:01:02.620 -- 00:01:04.540 Please take a moment to review the forward 00:01:04.540 -- 00:01:07.020 looking statements disclaimer at ...